Edition:
United States

People: Inovio Pharmaceuticals Inc (INO.O)

INO.O on Nasdaq

2.30USD
22 Aug 2019
Change (% chg)

$-0.06 (-2.54%)
Prev Close
$2.36
Open
$2.36
Day's High
$2.37
Day's Low
$2.23
Volume
493,015
Avg. Vol
935,340
52-wk High
$6.30
52-wk Low
$2.15

Humeau, Laurent 

Dr. Laurent Humeau is Chief Scientific Officer of the Company. Dr. Humeau has served as our Chief Scientific Officer since March 2019, having previously served as our Vice President and then Senior Vice President of Research and Development beginning in January 2014. Prior to joining us, Dr. Humeau was Senior Director of Translational Research, Human Therapeutics Division for Intrexon Corporation and previously served in a variety of roles, including Chief Scientific Officer and Vice President of Research and Development, at VIRxSYS Corporation. Dr. Humeau holds a Ph.D., summa cum laude, from Denis Diderot University (Paris 7) and a M.S. degree in Biology from Pierre & Marie Curie University (Paris 6).

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Simon Benito

151,301

Jong Kim

3,081,040

Peter Kies

1,331,610

Jacqueline Shea

--

Laurent Humeau

--

David Weiner

447,636
As Of  30 Dec 2018